2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Sato H et al. | Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy. | 2013 | Int J Pharm | pmid:23528280 |
| Evenbratt H et al. | In vivo study of an instantly formed lipid-water cubic phase formulation for efficient topical delivery of aminolevulinic acid and methyl-aminolevulinate. | 2013 | Int J Pharm | pmid:23727140 |
| Vicentini FT et al. | Liquid crystalline phase nanodispersions enable skin delivery of siRNA. | 2013 | Eur J Pharm Biopharm | pmid:23010565 |
| Li J et al. | A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. | 2013 | Int J Pharm | pmid:23916822 |
| Bitan-Cherbakovsky L et al. | Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid. | 2013 | Colloids Surf B Biointerfaces | pmid:23973908 |
| Liu H et al. | The effect of surface charge of glycerol monooleate-based nanoparticles on the round window membrane permeability and cochlear distribution. | 2013 | J Drug Target | pmid:23944216 |
| Dai J and Kim JC | Photo responsive monoolein cubic phase containing coumarin-Tween 20 conjugates. | 2013 | Drug Dev Ind Pharm | pmid:23902365 |
| Tangso KJ et al. | Novel spiropyran amphiphiles and their application as light-responsive liquid crystalline components. | 2013 | J Phys Chem B | pmid:23909814 |
| Esposito E et al. | Curcumin containing monoolein aqueous dispersions: a preformulative study. | 2013 | Mater Sci Eng C Mater Biol Appl | pmid:24094206 |
| Khvostichenko DS et al. | Effects of detergent β-octylglucoside and phosphate salt solutions on phase behavior of monoolein mesophases. | 2013 | Biophys. J. | pmid:24138861 |